Page 49 - Demo
P. 49
Treatment of ADH Disorders%u2022 Central DI: Desmopressin%u2022 Nephrogenic DI: High-dose desmopressin with/without thiazides and NSAIDsDiabetes Insipidus:%u2022 Fluid restriction (mild cases)%u2022 Demeclocycline%u2022 Vasopressin receptor antagonists: Conivaptan, tolvaptanSIADH:
